“Long-distance” COVID-19 shares some of the symptoms and biological abnormalities associated with chronic fatigue syndrome.”
More Info: UPI
As a result, they said, people who experience persistent symptoms that may persist for months after a coronavirus infection show chronic fatigue syndrome or myelogenous encephalomyelitis symptoms. According to the researchers, this includes redox imbalance, systemic inflammation, inflammation of the brain. And decreased metabolic rate in individuals with a hypometabolic condition — a non-functional thyroid gland. Redox imbalance, sometimes referred to as oxidative stress, is a disruption of antioxidants that the body uses to protect itself from the effects of antioxidants and the oxidative levels of molecules that can damage the molecules produced in the body and the environment.
Understanding what causes these changes in Chronic Fatigue Syndrome and Covid-19 can help researchers develop treatment options for conditions.
“Some doctors have speculated that chronic fatigue and chronic COVID-19 symptoms have no physical basis and that people may have imagined or fabricated their symptoms,” Bindu Paul, one of the authors of the report. About 75% of people with COVID-19 report symptoms within months, and recent research has shown that fatigue is usually the most common cause. And also, a study published earlier this year found that more than one in 10 people will experience fatigue. And the loss of taste or smell until nine months after the initial diagnosis. According to the Centers for Disease Control and Prevention, as the name suggests, Chronic Fatigue Syndrome is exacerbated by extreme fatigue, sleep disorders, pain, and other symptoms.
The agency estimates that about 2.5 million people in the United States suffer from chronic fatigue, many of which go undiagnosed. Significantly, research has shown that many patients with pneumonia or pneumonia due to COVID-19 show signs of a redox imbalance, as in chronic fatigue. Because of these potential connections, Paul and his colleagues said they would like to see more clinical trials of COVID-19 therapies that “enhance the redox imbalance and … [reduce] the inflammation that can cause it”.
Please let us know your opinions in the comments section below.